Bloodletting therapy for hyperlipidemia

The effect of bloodletting therapy for hyperlipidemia is generally not particularly obvious. Hyperlipidemia is a chronic disease and cannot be treated solely by bloodletting therapy, which may aggravate the condition.

Bloodletting therapy for hyperlipidemia mainly involves bleeding from the fingertips or ear tips, which can improve the condition. However, bloodletting therapy for hyperlipidemia can only provide temporary relief and cannot relieve the hyperlipidemia phenomenon. If the operation is improper, it will cause certain damage to the body, such as anemia and shock, and even increase the chance of local skin infection, seriously affecting physical and mental health. Therefore, bloodletting therapy for hyperlipidemia is not currently recommended.

Hyperlipidemia is a common clinical disease, which may be caused by eating high-fat foods for a long time or lack of physical activity. It is also possible that it has a certain relationship with secondary hyperlipidemia. For example, long-term use of certain drugs may cause hyperlipidemia. After the onset of the disease, patients will develop premature corneal rings, accompanied by fundus changes. As the disease progresses, symptoms of chest tightness and pain, as well as polyuria and polydipsia will also appear. Severe patients will have symptoms such as enlarged liver and spleen, affecting normal work and life. Patients need to take oral simvastatin drugs under the guidance of a doctor, and can also be treated with probucol drugs.